Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001121781-07-000075
Filing Date
2007-03-30
Accepted
2007-03-30 15:29:27
Documents
5
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 CYTOGENIX, INC. cyto10k123106.txt 10-K 208249
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER exhibit31one.htm EX-31.1 10737
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER exhibit31two.htm EX-31.2 10538
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER exhibit32one.htm EX-32.1 5126
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER exhibit32two.htm EX-32.2 4667
  Complete submission text file 0001121781-07-000075.txt   240853
Mailing Address 3100 WILCREST SUITE 140 HOUSTON TX 77042
Business Address 3100 WILCREST SUITE 140 HOUSTON TX 77042 7137890070
CYTOGENIX INC (Filer) CIK: 0001005302 (see all company filings)

EIN.: 760484097 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26807 | Film No.: 07732446
SIC: 8071 Services-Medical Laboratories